Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins-Reference-Cited by-同舟云学术

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

Published:2018-05-11 Issue:2 Volume:13 Page:184-200
ISSN:1574-8928
Container-title:Recent Patents on Anti-Cancer Drug Discovery
language:en
Short-container-title:PRA

Author:

Iannelli Federica¹,Lombardi Rita²,Milone Maria R.²,Pucci Biagio²,De Rienzo Simona¹,Budillon Alfredo¹,Bruzzese Francesca¹

Affiliation:

1. Experimental Pharmacology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Giovanni Pascale - IRCCS, 80131 Naples, Italy

2. Mercogliano Oncology Research Center (CROM), Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Giovanni Pascale - IRCCS, 80131 Naples, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Cancer Research,Drug Discovery,Oncology,General Medicine

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides as modulators of FPPS enzyme: a multifaceted evaluation from the design to the mechanism of action;European Journal of Medicinal Chemistry;2024-09

2. Statins in breast cancer treatment and management: a mini-review of potential benefits and clinical implications;International Journal of Surgery: Global Health;2024-07

3. Statins as anti‐tumor agents: A paradigm for repurposed drugs;Cancer Reports;2024-05

4. The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review;Cells;2024-03-14

5. Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer;Biomolecules;2024-01-03